Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Tissue-resident memory T cells (T), identified by CD103 expression, play key roles in infection and cancer and often correlate with improved survival in the latter. Their characterization in nasopharyngeal carcinoma (NPC) is of interest due to its viral etiology.
Methods: NPC tumors from patients treated at Peter MacCallum Cancer Centre (PMCC; 2000-2017) were examined for CD103, CD8 T cells, and PD-L1 abundance, correlated with survival, and underwent NanoString transcriptomic analysis. Additional cohorts from Hong Kong and Singapore were assessed for CD103 intra-tumoral immune cell (ITIC) abundance.
Results: Of the 141 PMCC patients, 29% (n = 30/103) of NPC tumors had high CD103 ITIC (defined as ≥ 30%) linked with T gene expression, immune checkpoints, and upregulated pathways in T-cell activation. Abundance of CD103 ITIC was not associated with improved survival (PMCC: HR = 0.9, 95% CI: 0.4-2.1) across all cohorts.
Conclusions: Despite similarities to other virally driven tumors, CD103 ITIC abundance was not prognostic in NPC, highlighting the need for better characterization of T subpopulations.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/hed.70026 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Examining CD103 Tissue-Resident Memory T Cells in Nasopharyngeal Carcinoma.
Head Neck
September 2025
Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.
Background: Tissue-resident memory T cells (T), identified by CD103 expression, play key roles in infection and cancer and often correlate with improved survival in the latter. Their characterization in nasopharyngeal carcinoma (NPC) is of interest due to its viral etiology.
Methods: NPC tumors from patients treated at Peter MacCallum Cancer Centre (PMCC; 2000-2017) were examined for CD103, CD8 T cells, and PD-L1 abundance, correlated with survival, and underwent NanoString transcriptomic analysis.
Prognostic stratification of HPV-associated oropharyngeal cancer based on CD103 immune cell abundance in patients treated on TROG 12.01 and De-ESCALaTE randomized trials.
Ann Oncol
August 2022
Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia.
Background: High CD103 intratumoral immune cell (ITIC) abundance is associated with better prognosis in unselected patients with human papilloma virus-associated oropharyngeal squamous cell carcinoma (HPV-associated OPSCC) treated with cisplatin and radiotherapy (CIS/RT). Substituting cetuximab (CETUX) for CIS with RT in HPV-associated OPSCC resulted in inferior efficacy. Our aim was to determine whether quantification of CD103 ITIC could be used to identify a population of HPV-associated OPSCC with superior prognosis.
View Article and Find Full Text PDF